Atıf Formatları
Proteomic profiling during atherosclerosis progression: Effect of nebivolol treatment
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. ÖZBEN SADIÇ Et Al. , "Proteomic profiling during atherosclerosis progression: Effect of nebivolol treatment," MOLECULAR AND CELLULAR BIOCHEMISTRY , vol.331, no.1-2, pp.9-17, 2009

ÖZBEN SADIÇ, B. Et Al. 2009. Proteomic profiling during atherosclerosis progression: Effect of nebivolol treatment. MOLECULAR AND CELLULAR BIOCHEMISTRY , vol.331, no.1-2 , 9-17.

ÖZBEN SADIÇ, B., Dursun, E., Monari, E., Cuoghi, A., Bergamini, S., Tomasi, A., ... Ozben, T.(2009). Proteomic profiling during atherosclerosis progression: Effect of nebivolol treatment. MOLECULAR AND CELLULAR BIOCHEMISTRY , vol.331, no.1-2, 9-17.

ÖZBEN SADIÇ, BESTE Et Al. "Proteomic profiling during atherosclerosis progression: Effect of nebivolol treatment," MOLECULAR AND CELLULAR BIOCHEMISTRY , vol.331, no.1-2, 9-17, 2009

ÖZBEN SADIÇ, BESTE Ö. Et Al. "Proteomic profiling during atherosclerosis progression: Effect of nebivolol treatment." MOLECULAR AND CELLULAR BIOCHEMISTRY , vol.331, no.1-2, pp.9-17, 2009

ÖZBEN SADIÇ, B. Et Al. (2009) . "Proteomic profiling during atherosclerosis progression: Effect of nebivolol treatment." MOLECULAR AND CELLULAR BIOCHEMISTRY , vol.331, no.1-2, pp.9-17.

@article{article, author={BESTE ÖZBEN SADIÇ Et Al. }, title={Proteomic profiling during atherosclerosis progression: Effect of nebivolol treatment}, journal={MOLECULAR AND CELLULAR BIOCHEMISTRY}, year=2009, pages={9-17} }